2025 Annual Meeting | C188 - Neurological Complications of Novel Anti-neoplastic Therapies Including Immunotherapy

Date Wednesday 04/09/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Location San Diego Convention Center | 25B

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Yazmin Odia, MD, MS, FAAN, FAAN

Topic(s) Neuro-oncology

Learning Objectives Participants should become familiar with the distinct types of anti-neoplastic therapies, including cytotoxic, biologic, hormone, immunotherapy, radiation, and other multimodaltherapies, and their unique neurological complications, as well as understand the underlying mechanisms of actions, interpret clinical and radiographic manifestations, and manage the neurological toxicities relative to the distincttypes of anti-neoplastic therapies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT	Introduction	Introduction Yazmin Odia, MD, MS, FAAN, FAAN
01:05 PM - 01:40 PM PDT	Speaker	Neurological Complications of Cytotoxic Chemotherapy Alexander Mohler, MD
01:40 PM - 02:15 PM PDT	Speaker	Neurological Complications of Immunotherapy Jose R. McFaline-Figueroa, MD, PhD
02:15 PM - 02:50 PM PDT	Speaker	Neurological Complications of Radiation and Multimodal Therapy Yazmin Odia, MD, MS, FAAN, FAAN
02:50 PM - 03:00 PM PDT	Q&A	Panel Discussion Yazmin Odia, MD, MS, FAAN, FAAN, Jose R. McFaline-Figueroa, MD, PhD, Alexander Mohler, MD

Faculty Disclosures
Yazmin Odia, MD, MS, FAAN, FAAN	Dr. Odia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PharPoint. Dr. Odia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GammaTile.
Jose R. McFaline-Figueroa, MD, PhD	The institution of Dr. McFaline-Figueroa has received research support from National Brain Tumor Society. The institution of Dr. McFaline-Figueroa has received research support from National Institutes of Health. The institution of Dr. McFaline-Figueroa has received research support from Robert Wood Johnson Foundation. Dr. McFaline-Figueroa has received publishing royalties from a publication relating to health care. Dr. McFaline-Figueroa has received publishing royalties from a publication relating to health care.
Alexander Mohler, MD	Dr. Mohler has nothing to disclose.

��ɫ��

��ɫ��